Dermata Therapeutics (DRMA) Research & Development (2020 - 2026)
Dermata Therapeutics (DRMA) posted quarterly Research & Development of $383724.0 for Q1 2026, down 94.52% year-over-year from $7.0 million in Q1 2025, and down 27.13% quarter-over-quarter from $526620.0 in Q4 2025.
Dermata Therapeutics (DRMA) Research & Development (2020 - 2026) Analysis & Trends
Dermata Therapeutics' Research & Development history runs 7 years deep, the most recent figure standing at $383724.0 for Q1 2026.
- In Q1 2026, Research & Development fell 94.52% year-over-year to $383724.0; the TTM figure through Mar 2026 stood at $2.0 million (down 85.06% YoY), while the FY2025 annual figure was $2.9 million, down 64.28% from the prior year.
- Research & Development for Q1 2026 stood at $383724.0, down from $526620.0 in the prior quarter.
- The five-year high for Research & Development was $7.0 million in Q1 2025, with the low at $383724.0 in Q1 2026.
- The 5-year median for Research & Development is $1.2 million (2023), against an average of $1.6 million.
- The sharpest annual moves came in 2025 and 2026: Research & Development surged 337.3% in 2025, then plunged 94.52% in 2026.
- Dermata Therapeutics' Research & Development stood at $889355.0 in 2022, then rose by 27.65% to $1.1 million in 2023, then jumped by 93.13% to $2.2 million in 2024, then sank by 75.98% to $526620.0 in 2025, then fell by 27.13% to $383724.0 in 2026.
- Business Quant data shows DRMA's Research & Development at $383724.0 in Q1 2026, $526620.0 in Q4 2025, and $504387.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 993.80 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.63 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 651.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 612.28 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 413.13 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 210.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 97.90 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -588.31 Mn |
| 10 | Dermata Therapeutics | 5.33 Mn | 5.33 Mn | - | 383,724.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 383,724.00 |
| Dec 31, 2025 | 526,620.00 |
| Sep 30, 2025 | 504,387.00 |
| Jun 30, 2025 | 617,835.00 |
| Mar 31, 2025 | 7.00 Mn |
| Dec 31, 2024 | 2.19 Mn |
| Sep 30, 2024 | 2.40 Mn |
| Jun 30, 2024 | 2.01 Mn |
| Mar 31, 2024 | 1.60 Mn |
| Dec 31, 2023 | 1.14 Mn |
| Sep 30, 2023 | 902,977.00 |
| Jun 30, 2023 | 838,931.00 |
| Mar 31, 2023 | 1.19 Mn |
| Dec 31, 2022 | 889,355.00 |
| Sep 30, 2022 | 1.55 Mn |
| Jun 30, 2022 | 1.61 Mn |
| Mar 31, 2022 | 1.60 Mn |
| Dec 31, 2021 | 1.11 Mn |
| Sep 30, 2021 | 799,779.00 |
| Jun 30, 2021 | 867,197.00 |